Developer docs
API playgroundTry for free, no card

Search company profiles

National Cancer Registry Ireland

Full company profile

uuid000mlpj

Namestring
National Cancer Registry Ireland
Legal namestring
National Cancer Registry Ireland
Websiteurl
ncri.ie
Company typeenum
Private
Founded yearint
1991
Descriptiontext

National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established by the Irish government in 1991 and operating its data-collection programme since 1994. NCRI collects, analyses, and disseminates comprehensive information on all cancer cases in Ireland — covering approximately 41,700 tumours and 9,800 cancer deaths per year (2020-2022 averages) — and serves as the authoritative national source for cancer incidence, survival, and mortality statistics used by the Health Service Executive, the Department of Health, academic researchers, clinicians, advocacy organisations (notably the Irish Cancer Society), and the general public.

NCRI's product surface comprises six core offerings: an interactive data dashboard for browsing and downloading cancer statistics; a publications programme (annual statistical reports, trend reports, factsheets, infographics, peer-reviewed articles); a structured custom data-request service; an EU-compliant open data portal; county-level cancer incidence maps; and a Secure Data Environment (SDE) launched in June 2026 in partnership with Aridhia. The SDE provides approved researchers with controlled, auditable access to anonymised or pseudonymised cancer data under FAIR data principles, and is positioned for alignment with the European Health Data Space. NCRI participates in European cancer-data initiatives including ENCR, ECIS, CancerWatch Joint Action, and Orion Joint Action.

As a publicly appointed state body, NCRI's revenue model is dominated by direct government funding allocations rather than commercial sales; core data access is free to all users, and revenue-generating activities are limited to commercial data-request fees (€100/hour), FOI internal review fees (€30 / €10 reduced), Information Commissioner review fees (€50 / €15 reduced), and capped search/retrieval charges (€20/hour, €0.04/sheet, ceiling €500-€700). The go-to-market motion is mandate-driven rather than sales-led: engagement is structured through open publication, webinars, European consortium participation, and earned media rather than commercial sales cycles.

Short descriptiontext

National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established in 1991, collecting and publishing comprehensive data on cancer incidence, survival, and mortality for the entire Irish population.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCork, Ireland
HQ citystring
Cork
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer registry services, cancer surveillance data, population health data, epidemiology research data, cancer statistics reporting
Industry4 codes
1Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer)
CodeHLAJANAGPrimaryYes
2Non-Communicable Disease Prevention & Chronic Disease Programs
CodeBPAIAJAIPrimaryNo
3Data Privacy, Confidentiality & Statistical Disclosure Control
CodeHLAJAJANPrimaryNo
4Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED)
CodeHLAJAJAMPrimaryNo
NAICS code1 code
  • Information51
Product category
Cancer Registry Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Government Funding
TypeSubscription Recurring
Description

NCRI is a publicly appointed body established in 1991, funded through government allocations as a statutory body. Core operations are supported by public sector funding rather than commercial revenue generation.

ncri.ie
2Data Request Fees
TypeUsage Based
Description

Charges of €100 per hour apply for commercial companies requesting data not routinely published by NCRI. FOI internal review fees of €30 (standard) or €10 (medical card holders) apply. Information Commissioner review fees are €50 (standard) or €15 (medical card holders/third parties). Search, retrieval and photocopying fees apply above €101 threshold, capped at €500 (or €700 upper limit).

ncri.ie
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Operations
Pricing details5 tiers
1Free open data access for general public
ModelFreemiumBilling cadencePay-as-you-go
Notes

All published reports, interactive dashboards, cancer factsheets, incidence maps, and open data are freely available on the NCRI website without charge. Non-personal data is made freely available except where specific reasons preclude release.

ncri.ie
2Commercial data request fee
ModelUsage-basedBilling cadencePay-as-you-go
Notes

€100 per hour for requests for information not routinely published, requiring substantial work to extract or prepare — applicable to commercial companies only.

ncri.ie
3FOI internal review fee
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€30 standard application fee; €10 for medical card holders or dependents. Free for personal information requests.

ncri.ie
4Information Commissioner review fee
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€50 standard; €15 for medical card holders or qualifying third parties under section 38(2).

ncri.ie
5Search, retrieval and photocopying
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€20 per hour for search and retrieval; €0.04 per sheet for photocopying. Minimum threshold of €101 below which no charge applies. Cap of €500 (or €700 upper ceiling limit).

ncri.ie
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

National Cancer Registry Ireland (NCRI) is a statutory public body that collects, classifies, analyses, and disseminates comprehensive population-based cancer data for Ireland. Its core offerings include interactive data dashboards, cancer incidence and survival statistics, annual statistical reports, cancer factsheets, downloadable incidence maps, open data, a formal data request service for custom queries, and a Secure Data Environment (SDE) for approved researcher access to anonymised individual-level cancer data.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Cancer diagnosis data collected for an average of 41,700 tumours per year (2020-2022), with national coverage of all cancer cases in Ireland
+6 more records
Product overview1 text field

National Cancer Registry Ireland operates as a public health data collection and reporting organization rather than a traditional software company. Its product portfolio centers on cancer surveillance data services, comprising an interactive data dashboard for browsing and downloading cancer statistics, published reports and publications (including annual statistical reports, cancer trend reports, factsheets, and infographics), a data request service for custom data queries, an open data initiative compliant with EU Open Data Directive, interactive cancer incidence maps at county level, and a Secure Data Environment (SDE) delivered in partnership with Aridhia for secure researcher access to sensitive cancer data. The offerings range from freely accessible public statistics to controlled-access research platforms, serving public health officials, researchers, clinicians, and the general public.

Product and service1 record
1Interactive Data Dashboard
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-30
Description

NCRI partnered with Aridhia to deliver a Secure Data Environment (SDE) for cancer research in Ireland. The SDE provides approved researchers with access to anonymised or pseudonymised cancer data within a secure, controlled digital setting. Aridhia brings advanced technology and expertise supporting a modern, scalable infrastructure for secure research collaboration. The initiative represents a significant step forward in how sensitive health data is accessed and used for research in Ireland.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The US federal government's principal agency for cancer research and surveillance (via its SEER program). Directly comparable as a national-level statutory cancer data and research authority, though far larger and operating across research, treatment, and policy.

2National Cancer Registration and Analysis Service (NCRAS), NHS England
TypeDirect peer
Description

England's population-based cancer registry within NHS Digital. Most direct functional peer to NCRI — collects, analyses, and disseminates cancer incidence, survival, and treatment data for the entire English population, with similar statutory mandate and European comparability.

3Swedish National Cancer Registry
TypeDirect peer
Description

One of the world's oldest population-based cancer registries (since 1958), operated by Sweden's National Board of Health and Welfare. Comparable scope (national coverage, statutory mandate) and co-participation in European cancer data networks (ENCR, ECIS).

4Cancer Registry of Norway
TypeDirect peer
Description

Norway's population-based cancer registry with national coverage, statutory mandate, and active role in Nordic and European cancer data collaboration. Operates at similar organisational scale and shares NCRI's ENCR/ECIS integration.

TypeDirect peer
Description

Statistics Canada's national cancer registry that compiles population-level incidence and survival data from provincial registries. Comparable as a federally-coordinated population cancer surveillance system, with similar mandate to support research and policy.

TypeDirect peer
Description

Australia's national cancer statistics authority (under AIHW), covering incidence, mortality, and survival for the entire Australian population. Comparable as a publicly-funded national cancer surveillance body with similar data dissemination functions.

TypeBroad incumbent
Description

WHO's specialised cancer research agency that coordinates global cancer surveillance (CI5, GLOBOCAN) and hosts the European Network of Cancer Registries (ENCR) that NCRI participates in. Comparable as the international coordinating body for cancer registry data and methods.

8European Cancer Information System (ECIS)
TypeOthers
Description

JRC-operated European cancer data dissemination platform to which NCRI contributes Ireland's data. Comparable as the supranational aggregation/distribution layer that NCRI feeds into, and a key benchmark for cross-country cancer indicator reporting.

TypeOthers
Description

Health-data analytics platform provider that partnered with NCRI in 2026 to deliver its Secure Data Environment. Comparable as the technology ecosystem partner enabling NCRI's secure researcher-access platform and similar SDE deployments for other public-sector health bodies.

10Irish Health Service Executive (HSE)
TypeRegional player
Description

Ireland's national health service delivery body and primary NCRI customer. Not a registry peer in the strict sense, but a critical institutional partner for cancer data — comparable as the principal downstream consumer of NCRI's surveillance data for service planning and policy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Cancer Registry Ireland

Cancer Registry Servicesncri.ie

National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established in 1991, collecting and publishing comprehensive data on cancer incidence, survival, and mortality for the entire Irish population.

What National Cancer Registry Ireland does

National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established by the Irish government in 1991 and operating its data-collection programme since 1994. NCRI collects, analyses, and disseminates comprehensive information on all cancer cases in Ireland — covering approximately 41,700 tumours and 9,800 cancer deaths per year (2020-2022 averages) — and serves as the authoritative national source for cancer incidence, survival, and mortality statistics used by the Health Service Executive, the Department of Health, academic researchers, clinicians, advocacy organisations (notably the Irish Cancer Society), and the general public.

NCRI's product surface comprises six core offerings: an interactive data dashboard for browsing and downloading cancer statistics; a publications programme (annual statistical reports, trend reports, factsheets, infographics, peer-reviewed articles); a structured custom data-request service; an EU-compliant open data portal; county-level cancer incidence maps; and a Secure Data Environment (SDE) launched in June 2026 in partnership with Aridhia. The SDE provides approved researchers with controlled, auditable access to anonymised or pseudonymised cancer data under FAIR data principles, and is positioned for alignment with the European Health Data Space. NCRI participates in European cancer-data initiatives including ENCR, ECIS, CancerWatch Joint Action, and Orion Joint Action.

As a publicly appointed state body, NCRI's revenue model is dominated by direct government funding allocations rather than commercial sales; core data access is free to all users, and revenue-generating activities are limited to commercial data-request fees (€100/hour), FOI internal review fees (€30 / €10 reduced), Information Commissioner review fees (€50 / €15 reduced), and capped search/retrieval charges (€20/hour, €0.04/sheet, ceiling €500-€700). The go-to-market motion is mandate-driven rather than sales-led: engagement is structured through open publication, webinars, European consortium participation, and earned media rather than commercial sales cycles.

National Cancer Registry Ireland firmographics

Firmographics
Name
National Cancer Registry Ireland
Legal name
National Cancer Registry Ireland
Website
https://ncri.ie
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established in 1991, collecting and publishing comprehensive data on cancer incidence, survival, and mortality for the entire Irish population.
Ownership category
akta.pro rank

National Cancer Registry Ireland industry classification

Industry
Product category
Cancer Registry Services
NAICS
Information (51)
akta.pro primary industry
Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG)
akta.pro secondary industries
Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI), Data Privacy, Confidentiality & Statistical Disclosure Control (HLAJAJAN), Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED) (HLAJAJAM)

Keywords

  • Cancer registry services
  • Cancer surveillance data
  • Population health data
  • Epidemiology research data
  • Cancer statistics reporting

Where National Cancer Registry Ireland is headquartered

Location

Headquarters

HQ city
Cork
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

National Cancer Registry Ireland business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Government Funding: NCRI is a publicly appointed body established in 1991, funded through government allocations as a statutory body. Core operations are supported by public sector funding rather than commercial revenue generation.
  2. Data Request Fees: Charges of €100 per hour apply for commercial companies requesting data not routinely published by NCRI. FOI internal review fees of €30 (standard) or €10 (medical card holders) apply. Information Commissioner review fees are €50 (standard) or €15 (medical card holders/third parties). Search, retrieval and photocopying fees apply above €101 threshold, capped at €500 (or €700 upper limit).

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree open data access for general public
Usage-basedPay-as-you-goCommercial data request fee
Unit PricingPay-as-you-goFOI internal review fee
Unit PricingPay-as-you-goInformation Commissioner review fee
Unit PricingPay-as-you-goSearch, retrieval and photocopying

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

National Cancer Registry Ireland product offering

Product offering

Core offering

National Cancer Registry Ireland (NCRI) is a statutory public body that collects, classifies, analyses, and disseminates comprehensive population-based cancer data for Ireland. Its core offerings include interactive data dashboards, cancer incidence and survival statistics, annual statistical reports, cancer factsheets, downloadable incidence maps, open data, a formal data request service for custom queries, and a Secure Data Environment (SDE) for approved researcher access to anonymised individual-level cancer data.

Product overview

National Cancer Registry Ireland operates as a public health data collection and reporting organization rather than a traditional software company. Its product portfolio centers on cancer surveillance data services, comprising an interactive data dashboard for browsing and downloading cancer statistics, published reports and publications (including annual statistical reports, cancer trend reports, factsheets, and infographics), a data request service for custom data queries, an open data initiative compliant with EU Open Data Directive, interactive cancer incidence maps at county level, and a Secure Data Environment (SDE) delivered in partnership with Aridhia for secure researcher access to sensitive cancer data. The offerings range from freely accessible public statistics to controlled-access research platforms, serving public health officials, researchers, clinicians, and the general public.

Differentiator

Problem solved

Functional benefit

Products and services

  • Interactive Data Dashboard

Quantifiable outcome

  • Cancer diagnosis data collected for an average of 41,700 tumours per year (2020-2022), with national coverage of all cancer cases in Ireland
  • +6 more outcomes

Companies that use National Cancer Registry Ireland

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

National Cancer Registry Ireland technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

National Cancer Registry Ireland partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AridhiacoreTechnology or Integration · 30 June 2026NCRI partnered with Aridhia to deliver a Secure Data Environment (SDE) for cancer research in Ireland. The SDE provides approved researchers with access to anonymised or pseudonymised cancer data within a secure, controlled digital setting. Aridhia brings advanced technology and expertise supporting a modern, scalable infrastructure for secure research collaboration. The initiative represents a significant step forward in how sensitive health data is accessed and used for research in Ireland.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

National Cancer Registry Ireland competitors and assessment

Company assessment

Broad incumbents

  • National Cancer Institute (NCI): The US federal government's principal agency for cancer research and surveillance (via its SEER program). Directly comparable as a national-level statutory cancer data and research authority, though far larger and operating across research, treatment, and policy.
  • International Agency for Research on Cancer (IARC): WHO's specialised cancer research agency that coordinates global cancer surveillance (CI5, GLOBOCAN) and hosts the European Network of Cancer Registries (ENCR) that NCRI participates in. Comparable as the international coordinating body for cancer registry data and methods.

Direct peers

  • National Cancer Registration and Analysis Service (NCRAS), NHS England: England's population-based cancer registry within NHS Digital. Most direct functional peer to NCRI — collects, analyses, and disseminates cancer incidence, survival, and treatment data for the entire English population, with similar statutory mandate and European comparability.
  • Swedish National Cancer Registry: One of the world's oldest population-based cancer registries (since 1958), operated by Sweden's National Board of Health and Welfare. Comparable scope (national coverage, statutory mandate) and co-participation in European cancer data networks (ENCR, ECIS).
  • Cancer Registry of Norway: Norway's population-based cancer registry with national coverage, statutory mandate, and active role in Nordic and European cancer data collaboration. Operates at similar organisational scale and shares NCRI's ENCR/ECIS integration.
  • Canadian Cancer Registry (Statistics Canada): Statistics Canada's national cancer registry that compiles population-level incidence and survival data from provincial registries. Comparable as a federally-coordinated population cancer surveillance system, with similar mandate to support research and policy.
  • Australian Institute of Health and Welfare (AIHW) — Cancer Database: Australia's national cancer statistics authority (under AIHW), covering incidence, mortality, and survival for the entire Australian population. Comparable as a publicly-funded national cancer surveillance body with similar data dissemination functions.

Others

  • European Cancer Information System (ECIS): JRC-operated European cancer data dissemination platform to which NCRI contributes Ireland's data. Comparable as the supranational aggregation/distribution layer that NCRI feeds into, and a key benchmark for cross-country cancer indicator reporting.
  • Aridhia: Health-data analytics platform provider that partnered with NCRI in 2026 to deliver its Secure Data Environment. Comparable as the technology ecosystem partner enabling NCRI's secure researcher-access platform and similar SDE deployments for other public-sector health bodies.

Regional players

  • Irish Health Service Executive (HSE): Ireland's national health service delivery body and primary NCRI customer. Not a registry peer in the strict sense, but a critical institutional partner for cancer data — comparable as the principal downstream consumer of NCRI's surveillance data for service planning and policy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

National Cancer Registry Ireland social profiles

Digital presence

National Cancer Registry Ireland compliance and trust

Trust signal

Compliance2 records

National Cancer Registry Ireland financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Cancer Registry Ireland leadership team

Management profile

Number of profiles

Profiles6 records

National Cancer Registry Ireland funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Cancer Registry Ireland M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Cancer Registry Ireland

What does National Cancer Registry Ireland do?

National Cancer Registry Ireland (NCRI) is a statutory public body that collects, classifies, analyses, and disseminates comprehensive population-based cancer data for Ireland. Its core offerings include interactive data dashboards, cancer incidence and survival statistics, annual statistical reports, cancer factsheets, downloadable incidence maps, open data, a formal data request service for custom queries, and a Secure Data Environment (SDE) for approved researcher access to anonymised individual-level cancer data.

Is National Cancer Registry Ireland a public or private company?

National Cancer Registry Ireland is a private company. It is classified as state government owned and is currently operating.

When was National Cancer Registry Ireland founded?

National Cancer Registry Ireland was founded in 1991. It employs 11 to 50 people.

Where is National Cancer Registry Ireland based?

National Cancer Registry Ireland is headquartered in Cork, Ireland, in the Europe region.

How does National Cancer Registry Ireland make money?

Two revenue lines are on record. Government Funding is the primary driver. The others are data Request Fees.

Who are National Cancer Registry Ireland's main competitors?

Broad incumbents on record are National Cancer Institute (NCI) and International Agency for Research on Cancer (IARC). Direct peers are National Cancer Registration and Analysis Service (NCRAS), NHS England, Swedish National Cancer Registry, Cancer Registry of Norway, Canadian Cancer Registry (Statistics Canada) and Australian Institute of Health and Welfare (AIHW) — Cancer Database. Others are European Cancer Information System (ECIS) and Aridhia. Irish Health Service Executive (HSE) is listed as a regional player.

Does National Cancer Registry Ireland have an API?

No public API is recorded for National Cancer Registry Ireland.

What industry is National Cancer Registry Ireland in?

National Cancer Registry Ireland's product category is Cancer Registry Services. Its primary akta.pro industry code is HLAJANAG, Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer), with a secondary code of BPAIAJAI, Non-Communicable Disease Prevention & Chronic Disease Programs. Its NAICS code is 51.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Irish TimesThe Irish Times view on cancer outcomes: a good news storyIreland's National Cancer Registry reports overall five-year survival for invasive cancers rose from 50% to 66% over two decades, with over 200,000 survivors. The registry also notes falling death rates and lower underlying cancer risk. Delays persist in colonoscopies and radiation, and Ireland trails European peers on treatment guarantees and drug reimbursement.RTE.ieCancer outcomes improved over three decadesData from the National Cancer Registry of Ireland reveals sustained improvements in cancer outcomes over the last three decades, with five-year survival for invasive cancers rising from 50% to 66%. This progress is attributed to earlier diagnosis and treatment advances, resulting in lower relative death rates for cervical and colorectal cancers compared to other EU states. Although total diagnoses continue to rise due to demographic changes, age-adjusted incidence rates have actually declined in both men and women.The Irish TimesRising cancer diagnoses reflect population growth and ageing but mortality rate improvingA new report from the National Cancer Registry Ireland reveals that while cancer diagnoses have risen due to population growth and aging, survival rates have improved substantially over the past 20 years. The study indicates that five-year survival rates now reach two-thirds for all cancers combined, driven by earlier detection and advanced treatments, with mortality significantly lower than the EU average for those under 75. Prostate and breast cancers remain the most common diagnoses, while lung cancer continues to be the leading cause of cancer death despite overall declining mortality trends.